WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2017191627) ANTIBODIES TO INTERLEUKIN 13 RECEPTOR ALPHA-1 (IL-13R ALPHA 1) AND USES THEREOF
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2017/191627 International Application No.: PCT/IL2017/050479
Publication Date: 09.11.2017 International Filing Date: 30.04.2017
IPC:
C07K 16/28 (2006.01) ,A61K 39/395 (2006.01) ,G01N 33/53 (2006.01) ,A61P 35/00 (2006.01) ,A61P 37/08 (2006.01)
Applicants: RAMOT AT TEL-AVIV UNIVERSITY LTD.[IL/IL]; P.O. Box 39296 6139201 Tel Aviv, IL
Inventors: BENHAR, Itai; IL
MUNITZ, Ariel; IL
KARO-ATAR, Danielle; IL
BITTON, Almog; IL
Agent: HORNIK, Vered; WEBB & CO. P.O. BOX 2189 7612101 REHOVOT, IL
WEBB, Cynthia; IL
BARZAM, Maty; IL
BOGIN, Liora; IL
BURSTEIN, Tal; IL
FINAROV, Igal; IL
GANOR, Sharon; IL
HORNIK, Vered; IL
NOAH, Eran; IL
SCHICKLER, Hedva; IL
SCHVARTZ, Iris; IL
SILVERMAN, Eran; IL
TRAVITSKY, Nina; IL
WEBB, Yael; IL
ZIPOR, Gadi; IL
Priority Data:
62/330,27602.05.2016US
Title (EN) ANTIBODIES TO INTERLEUKIN 13 RECEPTOR ALPHA-1 (IL-13R ALPHA 1) AND USES THEREOF
(FR) ANTICORPS DIRIGÉS CONTRE LE RÉCEPTEUR ALPHA-1 DE L'INTERLEUKINE 13 (IL -13 R ALPHA 1) ET UTILISATIONS ASSOCIÉES
Abstract:
(EN) Disclosed are immunoglobulin molecules that bind interleukin 13 receptor alpha-1(IL-13R alpha 1). Polynucleotide sequences encoding these immunoglobulins and therapeutic and diagnostic compositions comprising them are also disclosed. Further disclosed are methods of treating and diagnosing conditions, such as asthma and atopic dermatitis that involved binding of IL-13R alpha 1 to at least one ligand.
(FR) L'invention concerne des molécules d'immunoglobuline qui se lient au récepteur alpha-1 de l'interleukine 13 (IL -13 R alpha 1). L'invention concerne également des séquences de polynucléotides codant pour ces immunoglobulines et des compositions thérapeutiques et diagnostiques les comprenant. L'invention concerne en outre des procédés de traitement et de diagnostic d'états, tels que l'asthme et la dermatite atopique, qui impliquent la liaison de l'IL -13 R alpha 1 à au moins un ligand.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)